DAX rises to its highest level in almost three months thanks to a friendly start to the US stock market

Transparenz: Redaktionell erstellt und geprüft.
Veröffentlicht am

According to a report from www.schwarzwaelder-bote.de, the German stock market developed positively on Wednesday. The DAX rose to its highest level in almost three months. The leading index closed with an increase of 0.36 percent to 15,957.82 points. The MDax of medium-sized companies also recorded an increase of 0.72 percent to 26,135.95 points. In addition, profits were mainly recorded across Europe and in the USA. However, Bayer shares fell 3.4 percent and fell to their lowest level since 2006. This is due to the termination of a clinical trial with the drug Asundexian and the glyphosate litigation in the...

Gemäß einem Bericht von www.schwarzwaelder-bote.de, hat sich der deutsche Aktienmarkt am Mittwoch positiv entwickelt. Der DAX stieg auf den höchsten Stand seit fast drei Monaten. Der Leitindex schloss mit einem Plus von 0,36 Prozent auf 15.957,82 Punkte. Auch der MDax der mittelgroßen Unternehmen verzeichnete einen Anstieg von 0,72 Prozent auf 26.135,95 Zähler. Zudem wurden auch europaweit und in den USA überwiegend Gewinne verbucht. Die Aktien von Bayer verzeichneten jedoch ein Minus von 3,4 Prozent und fielen auf den tiefsten Stand seit 2006. Dies ist auf den Abbruch einer klinischen Studie mit dem Medikament Asundexian und auf den Glyphosat-Rechtsstreit in den …
According to a report from www.schwarzwaelder-bote.de, the German stock market developed positively on Wednesday. The DAX rose to its highest level in almost three months. The leading index closed with an increase of 0.36 percent to 15,957.82 points. The MDax of medium-sized companies also recorded an increase of 0.72 percent to 26,135.95 points. In addition, profits were mainly recorded across Europe and in the USA. However, Bayer shares fell 3.4 percent and fell to their lowest level since 2006. This is due to the termination of a clinical trial with the drug Asundexian and the glyphosate litigation in the...

DAX rises to its highest level in almost three months thanks to a friendly start to the US stock market

According to a report by www.schwarzwaelder-bote.de, the German stock market developed positively on Wednesday. The DAX rose to its highest level in almost three months. The leading index closed with an increase of 0.36 percent to 15,957.82 points. The MDax of medium-sized companies also recorded an increase of 0.72 percent to 26,135.95 points. In addition, profits were mainly recorded across Europe and in the USA.

However, Bayer shares fell 3.4 percent and fell to their lowest level since 2006. This is due to the termination of a clinical trial with the drug Asundexian and the glyphosate litigation in the USA.

On the other hand, the shareholders of the industrial company Thyssenkrupp received an unchanged dividend of 15 cents per share despite write-downs on the steel business. The shares rose to their highest level since the beginning of October.

The Eurozone index EuroStoxx 50 and in Paris also rose, while the Dow Jones Industrial rose by 0.6 percent at the European market close.

The euro fell to $1.0875 and the European Central Bank (ECB) set the reference rate at $1.0911. The dollar therefore cost 0.9165 euros. On the bond market, the current yield fell from 2.62 percent the previous day to 2.59 percent.

In view of these developments, it appears that the German stock market and global stock exchanges are in a positive mood. Despite some setbacks at certain companies, particularly Bayer, the market is showing general resilience. The developments suggest that investors continue to have confidence in the market and are willing to invest capital.

Read the source article at www.schwarzwaelder-bote.de

To the article